Literature DB >> 3676605

Assessing the functional value of relatives' knowledge about schizophrenia: a preliminary report.

C Barrowclough1, N Tarrier, S Watts, C Vaughn, J S Bamrah, H L Freeman.   

Abstract

An instrument for assessing and evaluating what relatives know about schizophrenia was evaluated as both a pre- and a post-test for an educational programme. The Knowledge About Schizophrenia Interview (KASI) places emphasis on the functional value of the reported knowledge rather than on the recall of information; it is quick, easy to administer, can be rated reliably, and has face-validity for the relative. The educational programme increased scores from pre-test to a post-test one week after the programme. Relatives with high criticism ratings on the Camberwell Family Interview had lower scores at both tests. Relatives of less chronic patients showed lower scores at pre-test and acquired significantly more information from the programme, while relatives of more chronic patients were less influenced by the information sessions.

Entities:  

Mesh:

Year:  1987        PMID: 3676605     DOI: 10.1192/bjp.151.1.1

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

1.  Educating relatives of schizophrenic patients.

Authors:  R Berkowitz; N Shavit; J P Leff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-07       Impact factor: 4.328

Review 2.  The stigma of severe mental illness: some potential solutions for a recalcitrant problem.

Authors:  D L Penn; J Martin
Journal:  Psychiatr Q       Date:  1998

Review 3.  Psychoeducation for schizophrenia.

Authors:  Jun Xia; Lars Bertil Merinder; Madhvi R Belgamwar
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

4.  Designing psychoeducational services for spouses of persons with serious mental illness.

Authors:  E Mannion; K Mueser; P Solomon
Journal:  Community Ment Health J       Date:  1994-04

5.  Randomised trial of personalised computer based information for patients with schizophrenia.

Authors:  R B Jones; J M Atkinson; D A Coia; L Paterson; A R Morton; K McKenna; N Craig; J Morrison; W H Gilmour
Journal:  BMJ       Date:  2001-04-07

6.  The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse.

Authors:  K Vaughan; M Doyle; N McConaghy; A Blaszczynski; A Fox; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-01       Impact factor: 4.328

7.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

8.  Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

Authors:  Kit Wa Sherry Chan; Men Heng Marian Wong; Christy Lai Ming Hui; Edwin Ho Ming Lee; Wing Chung Chang; Eric Yu Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

9.  Beginning schizophrenia observed by significant others.

Authors:  M Hambrecht; H Häfner; W Löffler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-04       Impact factor: 4.328

10.  Collaborative community based care for people and their families living with schizophrenia in India: protocol for a randomised controlled trial.

Authors:  Sudipto Chatterjee; Morven Leese; Mirja Koschorke; Paul McCrone; Smita Naik; Sujit John; Hamid Dabholkar; Kimberley Goldsmith; Madhumitha Balaji; Mathew Varghese; Rangaswamy Thara; Vikram Patel; Graham Thornicroft
Journal:  Trials       Date:  2011-01-13       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.